FAFTFSNP
REGN icon

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Regeneron Pharmaceuticals REGN Stock Holding History

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$30.7M Buy
+29,252
New +$28.4M 0.35% 50

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s REGN Position: Q2 2024 in Review

Fjarde AP-fonden (The Fourth Swedish National Pensionfund) opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2024: 29,252 shares worth $30.7M. The stake represents 0.35% of the portfolio and ranks #50 among its holdings.

1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • Fjarde AP-fonden (The Fourth Swedish National Pensionfund) held 29,252 shares of Regeneron Pharmaceuticals worth $30.7M as of Q2 2024.
  • Regeneron Pharmaceuticals was a new Fjarde AP-fonden (The Fourth Swedish National Pensionfund) position in Q2 2024.
  • Regeneron Pharmaceuticals made up 0.35% of Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s portfolio in Q2 2024, its #50 holding.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Fjarde AP-fonden (The Fourth Swedish National Pensionfund)'s 13F filing for Q2 2024, filed 2 Aug 2024.